Geoffrey S Hird

Title: Innovations of Geoffrey S. Hird in Pharmaceutical Formulations.

Introduction

Geoffrey S. Hird is a notable inventor based in Chapel Hill, NC (US). He has made significant contributions to the field of pharmaceutical formulations, particularly focusing on compounds that interact with non-NMDA receptors. His work is characterized by a commitment to advancing medical science through innovative solutions.

Latest Patents

Geoffrey S. Hird holds a patent for "Aqueous based pharmaceutical formulations of 1,2-dihydropyridine compounds." This patent describes an aqueous pharmaceutical formulation that includes a solubilizing agent with a pyridone compound. This formulation is particularly useful as an inhibitor to non-NMDA receptors, especially the AMPA receptor. In certain embodiments, the pyridone compound is supersaturated in aqueous solution at a pH between 6 and 8. These formulations are especially beneficial for intravenous injections.

Career Highlights

Geoffrey S. Hird is associated with Eisai R&D Management Co., Ltd., where he continues to contribute to pharmaceutical research and development. His expertise in creating effective formulations has positioned him as a valuable asset in the industry.

Collaborations

Geoffrey has collaborated with talented individuals such as Ganesh S. P. Bommareddy and Anjali Joshi. These collaborations have further enhanced the innovative work being done in the field of pharmaceutical formulations.

Conclusion

Geoffrey S. Hird's contributions to pharmaceutical formulations demonstrate his dedication to innovation in medical science. His patent and collaborative efforts reflect a commitment to improving therapeutic options for patients.